Edition:
United States

Nihon Trim Co Ltd (6788.T)

6788.T on Tokyo Stock Exchange

4,220JPY
7 Dec 2016
Change (% chg)

¥20 (+0.48%)
Prev Close
¥4,200
Open
¥4,200
Day's High
¥4,230
Day's Low
¥4,175
Volume
45,000
Avg. Vol
72,906
52-wk High
¥8,350
52-wk Low
¥3,665

Latest Key Developments (Source: Significant Developments)

Nihon Trim unit to sell entire 80 pct stake in TrimGen Corporation to China firm
Tuesday, 16 Aug 2016 02:51am EDT 

Nihon Trim Co Ltd <6788.T>: Says its holdings unit signed contract to sell entire 80 percent stake in its unit TrimGen Corporation to a China-based firm, Lifetree Biotechnology Co., Ltd . Says the unit will also forgive all the debt of TrimGen Corporation(about 685 million yen) based on the contract . Says the share transfer effective Aug. 16 .Says TrimGen Corporation is engaged in development, production and sales of genetic diagnostic kits, based in U.S..  Full Article

NIHON TRIM to enter hospital management business in China
Tuesday, 26 Apr 2016 12:00am EDT 

NIHON TRIM CO LTD:Says its group company to enter hospital management business in China and established jv named Han Kun International Holdings Limited in HK on Dec. 17, 2015, for Japanese medical business in China and development in Asia as well as related business.Says its group company holds 40 pct stake in Han Kun International Holdings Limited.  Full Article

NIHON TRIM sets up new unit in Korea
Monday, 25 Apr 2016 02:30am EDT 

NIHON TRIM CO LTD:Set up new unit Hankook TRIM CO., LTD. in Korea, on April 20.Unit is engaged in sale of water purifier and water treatment cartridge.  Full Article

NIHON TRIM raises year-end dividend forecast for FY 2016
Tuesday, 5 Jan 2016 01:30am EST 

NIHON TRIM CO LTD:Says it raised the year-end dividend forecast to 60 yen per share from 50 yen per share for the fiscal year ending March 2016.  Full Article

NIHON TRIM to divest stake in subsidiary
Thursday, 19 Mar 2015 02:30am EDT 

NIHON TRIM CO LTD:To sell 3,934 shares (56.57 pct voting rights) of subsidiary StemCell Institute to an Osaka-based holding subsidiary, for 944 mln yen, on March 30.To hold no stake in StemCell Institute.  Full Article